Cases & Deals

Amolyt Pharma raises $80 million in Series B financing round

Clients Amolyt Pharma

Jones Day advised Amolyt Pharma, a French based company engaged in the research and development of new therapeutic strategies for the treatment of rare endocrine and metabolic diseases, in connection with its $80 million Series B round of financing co-led by Sectoral Asset Management and Andera Partners.